eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.depression in male partner may lower pregnancy chances
.
.
.
sections
.
.
cutting luxuries could give savers extra ?10k in retirement
.
check out original content and videos published every day to help you learn about the issues that mean the most to you.
.
gelfand noted the impact on hdl may be balanced by the improvement seen in markers of
.
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.